Complete inhibition of liver acetyl-CoA carboxylase activity is required to exacerbate liver tumorigenesis in mice treated with diethylnitrosamine
Abstract Background The metabolic pathway of de novo lipogenesis (DNL) is upregulated in fatty liver disease and liver cancer. Inhibitors of DNL are in development for the treatment of these disorders; however, our previous study showed that blocking DNL unexpectedly exacerbated liver tumorigenesis...
Príomhchruthaitheoirí: | , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
BMC
2024-11-01
|
Sraith: | Cancer & Metabolism |
Ábhair: | |
Rochtain ar líne: | https://doi.org/10.1186/s40170-024-00363-1 |